AI Science Tracker
EN

Learned screening guides a blood-marker comparison between stroke subtypes

Nanyang Normal University; Nanyang Central Hospital · 28 Jun 2024 · medicine

Discovery

Learned screening guides a blood-marker comparison between stroke subtypes

Source check: Source checked. Not independent scientific confirmation.

Finding: Learned feature screening nominated FCER1G for a subsequent clinical blood-expression check. In the source’s selected samples, the marker differed between 36 cardioembolic and 25 large-artery stroke cases, with an apparent AUC of 0.8444. This preliminary result does not establish an early diagnostic test or a causal immune mechanism.

Technology: LASSO; random forest

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Fitted LASSO and random forest selected the marker for the later expression comparison; network analysis alone is not credited as enabling AI.
Test and result
LASSO and RF intersected with a coexpression screen to select FCER1G. The original clinical assay series contained 98 samples across five groups; the represented contrast is cardioembolic versus large-artery stroke.
Limitation / still unknown
Discovery combined blood and atrial-tissue datasets with different phenotypes, which limits interpretation of the screening model. The clinical comparison is small, selected and subject to age and cardiovascular comorbidity confounding. The apparent AUC comes from the same assayed cases, not an external diagnostic test. The separate nomogram includes cardiogenic-etiology information and is not represented as an independent prediction result. Laboratory procedures were not independently reviewed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11283116/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11283116/unicode

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary feature-selection Methods and high-level original clinical expression Results; assay protocols excluded.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.